Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa A Beck

Showing results (131-140 of 181) with videos related to

Pageof 19
Sort By:
American Journal of Clinical Dermatology|May 9, 2019
Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled AnalysisLawrence F Eichenfield, Thomas Bieber, Lisa A Beck, et al.
Eclinicalmedicine|January 27, 2025
Roads to remission: evolving treatment concepts in type 2 inflammatory diseasesMarek Lommatzsch, Katharina Blumchen, Lisa A Beck, et al.
The Journal of Allergy and Clinical Immunology|September 8, 2015
Targeted deep sequencing identifies rare loss-of-function variants in IFNGR1 for risk of atopic dermatitis complicated by eczema herpeticumLi Gao, Lianghua Bin, Nicholas M Rafaels, et al.
Journal of the American Academy of Dermatology|July 7, 2026
Dupilumab treatment improves linear growth and bone biomarkers in children with atopic dermatitis: Post hoc analysis of a phase 3 randomized, placebo-controlled clinical trial and an open-label extension studyAlan D Irvine, Amy S Paller, Elaine C Siegfried, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 14, 2023
Phenotypic and Endotypic Determinants of Atopic Dermatitis Severity From the Atopic Dermatitis Research Network (ADRN) RegistryEric L Simpson, Anna De Benedetto, Mark Boguniewicz, et al.
The Journal of Allergy and Clinical Immunology|July 19, 2011
The signal transducer and activator of transcription 6 gene (STAT6) increases the propensity of patients with atopic dermatitis toward disseminated viral skin infectionsMichael D Howell, Peisong Gao, Byung Eui Kim, et al.
The Journal of Allergy and Clinical Immunology|September 29, 2024
CERS1 is a biomarker of Staphylococcus aureus abundance and atopic dermatitis severityH Mark Kenney, Takeshi Yoshida, Evgeny Berdyshev, et al.
Journal of Neurotrauma|November 16, 2018
Electrophysiological Guidance of Epidural Electrode Array Implantation over the Human Lumbosacral Spinal Cord to Enable Motor Function after Chronic ParalysisJonathan S Calvert, Peter J Grahn, Jeffrey A Strommen, et al.
The New England Journal of Medicine|July 10, 2014
Dupilumab treatment in adults with moderate-to-severe atopic dermatitisLisa A Beck, Diamant Thaçi, Jennifer D Hamilton, et al.
The Journal of Allergy and Clinical Immunology|April 5, 2011
Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-γ responseDonald Y M Leung, Pei-Song Gao, Dmitry N Grigoryev, et al.
Pageof 19

Showing results (131-140 of 181) with videos related to

Sort By:
Pageof 19
American Journal of Clinical Dermatology|May 9, 2019
Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled AnalysisLawrence F Eichenfield, Thomas Bieber, Lisa A Beck, et al.
Eclinicalmedicine|January 27, 2025
Roads to remission: evolving treatment concepts in type 2 inflammatory diseasesMarek Lommatzsch, Katharina Blumchen, Lisa A Beck, et al.
The Journal of Allergy and Clinical Immunology|September 8, 2015
Targeted deep sequencing identifies rare loss-of-function variants in IFNGR1 for risk of atopic dermatitis complicated by eczema herpeticumLi Gao, Lianghua Bin, Nicholas M Rafaels, et al.
Journal of the American Academy of Dermatology|July 7, 2026
Dupilumab treatment improves linear growth and bone biomarkers in children with atopic dermatitis: Post hoc analysis of a phase 3 randomized, placebo-controlled clinical trial and an open-label extension studyAlan D Irvine, Amy S Paller, Elaine C Siegfried, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 14, 2023
Phenotypic and Endotypic Determinants of Atopic Dermatitis Severity From the Atopic Dermatitis Research Network (ADRN) RegistryEric L Simpson, Anna De Benedetto, Mark Boguniewicz, et al.
The Journal of Allergy and Clinical Immunology|July 19, 2011
The signal transducer and activator of transcription 6 gene (STAT6) increases the propensity of patients with atopic dermatitis toward disseminated viral skin infectionsMichael D Howell, Peisong Gao, Byung Eui Kim, et al.
The Journal of Allergy and Clinical Immunology|September 29, 2024
CERS1 is a biomarker of Staphylococcus aureus abundance and atopic dermatitis severityH Mark Kenney, Takeshi Yoshida, Evgeny Berdyshev, et al.
Journal of Neurotrauma|November 16, 2018
Electrophysiological Guidance of Epidural Electrode Array Implantation over the Human Lumbosacral Spinal Cord to Enable Motor Function after Chronic ParalysisJonathan S Calvert, Peter J Grahn, Jeffrey A Strommen, et al.
The New England Journal of Medicine|July 10, 2014
Dupilumab treatment in adults with moderate-to-severe atopic dermatitisLisa A Beck, Diamant Thaçi, Jennifer D Hamilton, et al.
The Journal of Allergy and Clinical Immunology|April 5, 2011
Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-γ responseDonald Y M Leung, Pei-Song Gao, Dmitry N Grigoryev, et al.
Pageof 19